Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · VIKASLIFE

VIKASLIFE

ServicesCommercial Services & Supplies₹214 cr market cap
₹1.14 ▼ -0.87% today As of 19 Nov 2026
52-week low ₹1.0652-week high ₹2.03

-43.3% from the 52-week high · +8.5% above the low

Vikas Lifecare Ltd. engages in the trading of chemicals compounds. The company is headquartered in New Delhi, Delhi and currently employs 59 full-time employees. The company went IPO on 2019-05-08. The firm is also engaged in the business of manufacturing polyvinyl chloride (PVC) compounds and agro-processing units. The firm operates through eight segments: Real estate Division, Trading Division-Polymers, Trading Division -Agro, Trading Division - Infrastructure, Manufacturing Division - Cashew Nuts, Manufacturing Division- Polymers, Business facilitation service, and Meter Installation. The company is involved in the trading of various polymer compounds, such as ethylene-vinyl acetate (EVA Compounds), polyvinyl chloride resins (PVC resins), chlorinated paraffin, polyethylene compounds (PE Compounds) and thermoplastic rubber compounds (TPR Compounds). The company has also diversified its business into fast-moving consumer goods, lifecare products, and pharmaceuticals.

The short version. VIKASLIFE reported revenue of ₹169 crore for Mar 2026, up 25.2% from a year earlier. Net profit was ₹42 crore. Return on equity was 3.3% in Mar 2026. Promoter holding was 14.2% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

VIKASLIFE trades 43.3% below its 52-week high and 8.5% above its 52-week low.

Change over period: —

1M-1.7%
3M-5.0%
6M-19.6%
1Y-41.9%

2 · The business

Is it growing?

Sales, year on year+25.2%

Mar 2026 revenue of ₹169 cr.

Net margin24.7%

26.8 pts higher than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue169971419213511813592
Net profit42-29-119-3-3-72-3
Net margin %24.7-30.1-84.2-2.9-2.1-5.81.6-3.1
EPS (₹)0.22-0.16-0.64-0.01-0.02-0.040.01-0.02

Annual

FY2026FY2025FY2024FY2023FY2022
Revenue499480446476301
Net profit18-1114-1529
Net margin %3.7-2.33.1-3.29.5
EPS (₹)0.1-0.060.09-0.110.26

3 · The quality

How well does it turn capital into profit?

Return on equity was 3.3% in Mar 2026; debt to equity is 0.19.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %3.3-2.12.9-4.6
Return on capital %13.5-1.44.0-5.5
EBITDA margin %13.8-0.35.0-3.6
Net margin %2.9-2.23.0-3.4

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR12.3%—
Profit CAGR——
Debt to equity0.19
Interest cover12.5x
Current ratio1.65
P/E ratio11.6

4 · The owners

Who holds it, and are they adding?

Promoter holding14.2%

Unchanged over 8 quarters.

Foreign institutions0.26%

Down 0.23 pts over 8 quarters.

Mutual fund schemes0

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter14.214.214.214.214.214.214.214.20.0
FII0.490.460.380.30.280.260.260.26-0.23
DII000000000
Public85.3185.3485.4285.585.5285.5485.5485.54+0.23

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for VIKASLIFE are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about VIKASLIFE

What is the VIKASLIFE share price?

VIKASLIFE (VIKASLIFE) last closed at ₹1.14, down 0.87% on the day. Its 52-week range is ₹1.06 to ₹2.03.

What is the market cap of VIKASLIFE?

VIKASLIFE has a market capitalisation of about ₹214 crore. Its price-to-earnings ratio is 11.6.

How are VIKASLIFE's latest results?

VIKASLIFE reported revenue of ₹169 crore for Mar 2026, up 25.2% from a year earlier. Net profit was ₹42 crore. Return on equity was 3.3% in Mar 2026. Promoter holding was 14.2% in Sep 2026, up 0.00 points over 8 quarters.

Who owns VIKASLIFE?

As of Sep 2026, shareholding was: Promoter 14.2%, FII 0.26%, Public 85.54%.

How many mutual funds hold VIKASLIFE?

0 mutual fund schemes held VIKASLIFE in October 2026. That compares with 0 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 29 Oct 2021 · Rights issue 4:21
  • 20 May 2021 · Rights issue 2:5

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.